Home>>Signaling Pathways>> Microbiology & Virology>> Bacterial>>Sulfaquinoxaline sodium salt

Sulfaquinoxaline sodium salt

Catalog No.GC32393

Sulfaquinoxaline sodium salt is an antimicrobial for veterinary use, with activity against a broad spectrum of Gram-negative and Gram-positive bacteria.

Products are for research use only. Not for human use. We do not sell to patients.

Sulfaquinoxaline sodium salt Chemical Structure

Cas No.: 967-80-6

Size Price Stock Qty
10mM (in 1mL DMSO)
$50.00
In stock
100mg
$46.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Sulfaquinoxaline sodium salt is an antibiotic which has activity against a broad spectrum of Gram-negative and Gram-positive bacteria.

The antimicrobial Sulfaquinoxaline sodium salt has activity against a broad spectrum of Gram-negative and Gram-positive bacteria and is widely used in poultry production as therapeutic or prophylactic agent. Concentrations of Sulfaquinoxaline sodium salt that are higher than the drug's maximum residue limit (MRL) (100 μg/kg) are found in the breast muscle until the 36th day of breeding in this study[1].

[1]. de Assis DC, et al. Evaluation of the Presence and Levels of Enrofloxacin, Ciprofloxacin, Sulfaquinoxaline and Oxytetracycline in Broiler Chickens after Drug Administration. PLoS One. 2016 Nov 15;11(11):e0166402.

Reviews

Review for Sulfaquinoxaline sodium salt

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Sulfaquinoxaline sodium salt

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.